28456571|t|Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin - induced mitochondrial dysfunction and toxicity
28456571|a|The hormone erythropoietin (EPO) has been demonstrated to protect against chemotherapy drug doxorubicin (DOX)- induced cardiotoxicity, but the underlying mechanism remains obscure. We hypothesized that silent mating type information regulation 2 homolog 1 (SIRT1), an NAD(+)-dependent protein deacetylase that activates peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), plays a crucial role in regulating mitochondrial function and mediating the beneficial effect of EPO. Our study in human cardiomyocyte AC16 cells showed that DOX - induced cytotoxicity and mitochondrial dysfunction, as manifested by decreased mitochondrial DNA (mtDNA) copy number, mitochondrial membrane potential, and increased mitochondrial superoxide accumulation, can be mitigated by EPO pretreatment. EPO was found to upregulate SIRT1 activity and protein expression to reverse DOX - induced acetylation of PGC-1α and suppression of a suite of PGC-1α - activated genes involved in mitochondrial function and biogenesis, such as nuclear respiratory factor-1 (NRF1), mitochondrial transcription factor A (TFAM), citrate synthase (CS), superoxide dismutase 2 (SOD2), cytochrome c oxidase IV (COXIV), and voltage-dependent anion channel (VDAC). Silencing of SIRT1 via small RNA interference sensitized AC16 cells to DOX - induced cytotoxicity and reduction in mtDNA copy number. Although with SIRT1 silenced, EPO could reverse to some extent DOX - induced mitochondrial superoxide accumulation, loss of mitochondrial membrane potential and ATP depletion, it failed to normalize protein expression of PGC-1α and its downstream genes. Taken together, our results indicated that EPO may activate SIRT1 to enhance mitochondrial function and protect against DOX - induced cardiotoxicity.
28456571	0	14	Erythropoietin	T116,T121,T125	C0014822
28456571	25	30	SIRT1	T116,T126	C1101544
28456571	42	47	human	T016	C0086418
28456571	48	62	cardiomyocytes	T025	C0225828
28456571	63	70	against	T080	C0521124
28456571	71	82	doxorubicin	T109,T195	C0013089
28456571	85	92	induced	T169	C0205263
28456571	93	118	mitochondrial dysfunction	T033	C4021734
28456571	123	131	toxicity	T037	C0600688
28456571	136	143	hormone	T125	C0019932
28456571	144	158	erythropoietin	T116,T121,T125	C0014822
28456571	160	163	EPO	T116,T121,T125	C0014822
28456571	198	205	against	T080	C0521124
28456571	206	218	chemotherapy	T061	C3665472
28456571	219	223	drug	T121	C0013227
28456571	224	235	doxorubicin	T109,T195	C0013089
28456571	237	240	DOX	T109,T195	C0013089
28456571	243	250	induced	T169	C0205263
28456571	251	265	cardiotoxicity	T037	C0876994
28456571	286	295	mechanism	T169	C0441712
28456571	316	328	hypothesized	T078	C1512571
28456571	334	387	silent mating type information regulation 2 homolog 1	T116,T126	C1101544
28456571	389	394	SIRT1	T116,T126	C1101544
28456571	400	436	NAD(+)-dependent protein deacetylase	T116,T126	C1101544
28456571	452	520	peroxisome proliferator-activated receptor gamma coactivator 1-alpha	T116,T123	C1452082
28456571	522	528	PGC-1α	T116,T123	C1452082
28456571	566	588	mitochondrial function	UnknownType	C0678850
28456571	607	617	beneficial	T081	C0814225
28456571	618	624	effect	T080	C1280500
28456571	628	631	EPO	T116,T121,T125	C0014822
28456571	637	642	study	T062	C2603343
28456571	646	651	human	T016	C0086418
28456571	652	665	cardiomyocyte	T025	C0225828
28456571	666	676	AC16 cells	T025	C0682523
28456571	689	692	DOX	T109,T195	C0013089
28456571	695	702	induced	T169	C0205263
28456571	703	715	cytotoxicity	T049	C0596402
28456571	720	745	mitochondrial dysfunction	T033	C4021734
28456571	764	773	decreased	T081	C0205216
28456571	774	791	mitochondrial DNA	T114,T123	C0012929
28456571	793	798	mtDNA	T114,T123	C0012929
28456571	800	811	copy number	T081	C1707513
28456571	813	845	mitochondrial membrane potential	T043	C1720920
28456571	851	860	increased	T081	C0205217
28456571	861	885	mitochondrial superoxide	T116,T126	C1743497
28456571	886	898	accumulation	T033	C4055506
28456571	907	916	mitigated	T067	C1553901
28456571	920	923	EPO	T116,T121,T125	C0014822
28456571	924	936	pretreatment	T052	C3539076
28456571	938	941	EPO	T116,T121,T125	C0014822
28456571	955	965	upregulate	T044	C0041904
28456571	966	971	SIRT1	T116,T126	C1101544
28456571	972	980	activity	T044	C1537044
28456571	985	1003	protein expression	T045	C1171362
28456571	1007	1014	reverse	T169	C1555029
28456571	1015	1018	DOX	T109,T195	C0013089
28456571	1021	1028	induced	T169	C0205263
28456571	1029	1040	acetylation	T044	C1521754
28456571	1044	1050	PGC-1α	T116,T123	C1452082
28456571	1055	1066	suppression	T045	C0038855
28456571	1081	1087	PGC-1α	T116,T123	C1452082
28456571	1090	1099	activated	T052	C1879547
28456571	1100	1105	genes	T028	C0017337
28456571	1118	1140	mitochondrial function	UnknownType	C0678850
28456571	1145	1155	biogenesis	T070	C0005495
28456571	1165	1193	nuclear respiratory factor-1	T116,T123	C1565068
28456571	1195	1199	NRF1	T116,T123	C1565068
28456571	1202	1238	mitochondrial transcription factor A	T116,T123	C0965025
28456571	1240	1244	TFAM	T116,T123	C0965025
28456571	1247	1263	citrate synthase	T116,T126	C0008855
28456571	1265	1267	CS	T116,T126	C0008855
28456571	1270	1292	superoxide dismutase 2	T116,T126	C0968147
28456571	1294	1298	SOD2	T116,T126	C0968147
28456571	1301	1324	cytochrome c oxidase IV	T116,T126	C0010760
28456571	1326	1331	COXIV	T116,T126	C0010760
28456571	1338	1369	voltage-dependent anion channel	T116,T123	C1506024
28456571	1371	1375	VDAC	T116,T123	C1506024
28456571	1378	1387	Silencing	T045	C0598496
28456571	1391	1396	SIRT1	T028	C1423062
28456571	1407	1423	RNA interference	T045	C1136031
28456571	1424	1445	sensitized AC16 cells	T025	C0312864
28456571	1449	1452	DOX	T109,T195	C0013089
28456571	1455	1462	induced	T169	C0205263
28456571	1463	1475	cytotoxicity	T049	C0596402
28456571	1480	1489	reduction	T080	C0392756
28456571	1493	1498	mtDNA	T114,T123	C0012929
28456571	1499	1510	copy number	T081	C1707513
28456571	1526	1531	SIRT1	T028	C1423062
28456571	1532	1540	silenced	T045	C0598496
28456571	1542	1545	EPO	T116,T121,T125	C0014822
28456571	1552	1559	reverse	T169	C1555029
28456571	1575	1578	DOX	T109,T195	C0013089
28456571	1581	1588	induced	T169	C0205263
28456571	1589	1613	mitochondrial superoxide	T116,T126	C1743497
28456571	1614	1626	accumulation	T033	C4055506
28456571	1628	1632	loss	T081	C1517945
28456571	1636	1668	mitochondrial membrane potential	T043	C1720920
28456571	1673	1676	ATP	T114,T121,T123	C0001480
28456571	1677	1686	depletion	T169	C0333668
28456571	1711	1729	protein expression	T045	C1171362
28456571	1733	1739	PGC-1α	T116,T123	C1452082
28456571	1748	1758	downstream	T082	C0522506
28456571	1759	1764	genes	T028	C0017337
28456571	1809	1812	EPO	T116,T121,T125	C0014822
28456571	1826	1831	SIRT1	T116,T126	C2720167
28456571	1835	1842	enhance	T052	C2349975
28456571	1843	1865	mitochondrial function	UnknownType	C0678850
28456571	1878	1885	against	T080	C0521124
28456571	1886	1889	DOX	T109,T195	C0013089
28456571	1892	1899	induced	T169	C0205263
28456571	1900	1914	cardiotoxicity	T037	C0876994